Interleukin-12 as an Adjuvant for Cancer Immunotherapy
- 30 September 1999
- Vol. 19 (1) , 114-120
- https://doi.org/10.1006/meth.1999.0836
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Interleukin-12: An Immunoregulatory Cytokine Produced by B Cells and Antigen-Presenting CellsMethods, 1997
- IL-12 Gene Therapy Using Direct Injection of Tumors with Genetically Engineered Autologous Fibroblasts. University of Pittsburgh, Pittsburgh, PennsylvaniaHuman Gene Therapy, 1995
- Clinical Trials: IL-12 Deaths: Explanation and a PuzzleScience, 1995
- Interleukin-12 and malariaResearch in Immunology, 1995
- Interleukin-12 in the pathogenesis and therapy of HIV diseaseResearch in Immunology, 1995
- IL 12 in acute viral infectious diseaseResearch in Immunology, 1995
- The role of IL-12 in the induction of organ-specific autoimmune diseasesImmunology Today, 1995
- Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4.The Journal of Experimental Medicine, 1995
- Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivoEuropean Journal of Immunology, 1995
- CD4 T cells inhibitin vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genesEuropean Journal of Immunology, 1995